IFNA1 and systemic lupus erythematosus: Both abnormal levels of IFNs and alterations in IFN signaling pathways have been observed in RA, systemic lupus erythematosus (SLE), primary Sjögren syndrome (pSS), and other autoimmune diseases [11–13].